Antibody Microarrays in Clinical Proteomics
A special issue of BioTech (ISSN 2673-6284).
Deadline for manuscript submissions: closed (15 September 2015) | Viewed by 216
Special Issue Information
Dear Colleagues,
High throughput proteomic analysis provides powerful tools for the discovery of novel biomarkers, which could be used in the diagnosis and/or prognosis of diseases. Consequently, protein microarrays have been widely used for profiling biomarkers related with disease development and progression. The advantage of microarrays is that they allow for high throughput screening of large numbers of biomarkers, using minute amount of samples. This special issue will summarize the utilization of antibody microarrays and their implication in clinical settings. The focus will be both on recent technology developments in this field as well as the usefulness of this technique to demonstrate clinical utility and unmet medical needs, such as early diagnosis, patient stratification and evidence therapy selection.
Prof.Carl A. K. Borrebaeck
Prof. Christer Wingren
Dr. Ulrika Andreasson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. BioTech is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- proteomics
- antibody microarray
- clinical utility
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
